⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14845193 | 0.81 | TSHR (0.41) | — | |
| SCHEMBL8637692 | 0.79 | — | — | |
| SCHEMBL3296338 | 0.77 | — | — | |
| SCHEMBL2052963 | 0.77 | — | — | |
| SCHEMBL4247978 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL27646724 | 0.75 | — | — | |
| SCHEMBL27652499 | 0.75 | TSHR (0.41) | — | |
| SCHEMBL27497776 | 0.74 | — | — | |
| SCHEMBL1991500 | 0.73 | TSHR (0.38) | — | |
| SCHEMBL4021280 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3064199-B1 | ABUSE-DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS | BUZZZ PHARMACEUTICALS LTD (IE) | 2023-12-20 | — | — | EP | claimed |
| US-20210017201-A1 | ARF6 INHIBITORS AND RELATED METHODS | NAVIGEN, INC. | 2021-01-21 | — | — | US | claimed |
| EP-3672597-A2 | ARF6 INHIBITORS AND RELATED METHODS | Navigen, Inc. (US) | 2020-07-01 | — | — | EP | claimed |
| WO-2019040499-A2 | ARF6 INHIBITORS AND RELATED METHODS | NAVIGEN, INC. (US) | 2019-02-28 | — | — | WO | claimed |
| US-20150197484-A1 | USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES | ZYNERBA PHARMACEUTICALS, INC. (US) | 2015-07-16 | — | — | US | claimed |
| WO-2012148550-A1 | PRODRUGS OF THERAPEUTIC COMPOUNDS | MYREXIS, INC. (US) | 2012-11-01 | — | — | WO | claimed |
| EP-2473475-A1 | USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES | AllTranz Inc. (US) | 2012-07-11 | — | — | EP | claimed |
| US-20110052694-A1 | USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES | ALLTRANZ INC. (US) | 2011-03-03 | — | — | US | claimed |
| WO-2011026144-A1 | USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES | ALLTRANZ INC. (US) | 2011-03-03 | — | — | WO | claimed |
| CN-101815697-A | Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same | ALLTRANZ INC | 2010-08-25 | — | — | CN | claimed |
| US-20090036523-A1 | PRODRUGS OF CANNABIDIOL, COMPOSITIONS COMPRISING PRODRUGS OF CANNABIDIOL AND METHODS OF USING THE SAME | ALLTRANZ INC. (US) | 2009-02-05 | — | — | US | claimed |
| EP-1392718-B1 | IMPROVED NATIVE CHEMICAL LIGATION WITH THREE OR MORE COMPONENTS | GENEPROT INC (CH) | 2006-01-11 | — | — | EP | claimed |
| US-20050064538-A1 | Native chemical ligation with three or more components | ASTRAZENECA PHARMACEUTICALS LP | 2005-03-24 | — | — | US | claimed |
| EP-1392718-A2 | IMPROVED NATIVE CHEMICAL LIGATION WITH THREE OR MORE COMPONENTS | Geneprot, Inc. (CH) | 2004-03-03 | — | — | EP | claimed |
| US-20040038943-A1 | Indole and benzimidazole 15-lipoxygenase inhibitors | CONNOR DAVID THOMAS (US) | 2004-02-26 | — | — | US | claimed |
| EP-1294686-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2003-03-26 | — | — | EP | claimed |
| WO-2002098902-A2 | IMPROVED NATIVE CHEMICAL LIGATION WITH THREE OR MORE COMPONENTS | GENEPROT, INC. (CH) | 2002-12-12 | — | — | WO | claimed |
| WO-2001096299-A2 | INDOLE DERIVATIVES AND THEIR USE AS 15-LIPOXYGENASE INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-12-20 | — | — | WO | claimed |
| CN-1264377-A | Substituted pyrazoles as P38 kinase inhabitors | SEARLE & CO (US) | 2000-08-23 | — | — | CN | claimed |
| US-5786352-A | CARDIOVASCULAR DISORDERS, TACHYKININ RECEPTOR ANTAGONIST | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-07-28 | — | — | US | claimed |